Mariana Castanheira (Mariana Castanheria, M Castanheira)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 78

Top Topics

Pseudomonas Aeruginosa

Multidrug Resistant

Quality Control

Top Venues

Antimicrobial agents and chemotherapy

Microbiology spectrum

Journal of clinical microbiology

The Journal of antimicrobial chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy 68 (5) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Jeffrey B Locke, Chris M Pillar, Mariana Castanheira, Cecilia G Carvalhaes, David R Andes, Jalal A Aram, Christina Andrzejewski, Ken Bartizal, Anita F Das, Taylor Sandison, George R Thompson, Peter G Pappas
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis. Antimicrobial agents and chemotherapy (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Jeffrey B Locke, Chris M Pillar, Mariana Castanheira, Cecilia G Carvalhaes, David R Andes, Jalal A Aram, Christina Andrzejewski, Ken Bartizal, Anita F Das, Taylor Sandison, George R Thompson, Peter G Pappas
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Jeffrey B Locke, Chris M Pillar, Mariana Castanheira, Cecilia G Carvalhaes, David R Andes, Jalal A Aram, Christina Andrzejewski, Ken Bartizal, Anita F Das, Taylor Sandison, George R Thompson, Peter G Pappas
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy 68 (5) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy 68 (5) (2024)
Jeffrey B Locke, Chris M Pillar, Mariana Castanheira, Cecilia G Carvalhaes, David R Andes, Jalal A Aram, Christina Andrzejewski, Ken Bartizal, Anita F Das, Taylor Sandison, George R Thompson, Peter G Pappas
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis. Antimicrobial agents and chemotherapy 68 (5) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
Mariana Castanheira, John H Kimbrough, Jill Lindley, Timothy B Doyle, Jessica M Ewald, Helio Silva Sader
In vitro development of resistance against antipseudomonal agents: comparison of novel β-lactam/β-lactamase inhibitor combinations and other β-lactam agents. Antimicrobial agents and chemotherapy (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
Jeffrey B Locke, Chris M Pillar, Mariana Castanheira, Cecilia G Carvalhaes, David R Andes, Jalal A Aram, Christina Andrzejewski, Ken Bartizal, Anita F Das, Taylor Sandison, George R Thompson, Peter G Pappas
Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Mariana Castanheira, Lalitagauri M Deshpande, Paul R Rhomberg, Cecilia G Carvalhaes
Recent increase in Candida auris frequency in the SENTRY surveillance program: antifungal activity and genotypic characterization. Antimicrobial agents and chemotherapy (2024)
M A Pfaller, Cecilia Godoy Carvalhaes, P R Rhomberg, L M Desphande, Mariana Castanheira
Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021). Journal of clinical microbiology 62 (2) (2024)
Christophe Le Terrier, Patrice Nordmann, Chloé Buchs, Doris Yoong Wen Di, Gian Maria Rossolini, Roger Stephan, Mariana Castanheira, Laurent Poirel
Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern. The Journal of antimicrobial chemotherapy (2023)
Rodrigo Elisandro Mendes, S J Ryan Arends, Jennifer M Streit, Ian Critchley, Nicole Cotroneo, Mariana Castanheira
Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020). Microbiology spectrum (2023)
Mariana Castanheira, Rodrigo E Mendes, Ana C Gales
Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 76 (Supplement_2) (2023)
Dee Shortridge, Valerie Kantro, Mariana Castanheira
Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates. Microbiology spectrum 11 (1) (2023)
Mariana Castanheira, Rodrigo E Mendes, Ana C Gales
Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 76 (Supplement_2) (2023)
Rodrigo Elisandro Mendes, S J Ryan Arends, Jennifer M Streit, Ian Critchley, Nicole Cotroneo, Mariana Castanheira
Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020). Microbiology spectrum 11 (1) (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, John H Kimbrough, Valerie Kantro, Mariana Castanheira
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers. Open forum infectious diseases 10 (2) (2023)
Helio Silva Sader, Mariana Castanheira, John H Kimbrough, Valerie Kantro, Rodrigo Elisandro Mendes
Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21). JAC-antimicrobial resistance 5 (2) (2023)
Rodrigo Elisandro Mendes, S J Ryan Arends, Jennifer M Streit, Ian Critchley, Nicole Cotroneo, Mariana Castanheira
Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020). Microbiology spectrum 11 (1) (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum 11 (1) (2023)
Dee Shortridge, Valerie Kantro, Mariana Castanheira
Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates. Microbiology spectrum 11 (1) (2023)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Mariana Castanheira
Susceptibility patterns of amphotericin B, itraconazole, posaconazole, voriconazole and caspofungin for isolates causing invasive mould infections from the SENTRY Antifungal Surveillance Program (2018-2021) and application of single-site epidemiological cutoff values to evaluate amphotericin B activity. Mycoses (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, Cecilia Godoy Carvalhaes, John H Kimbrough, Mariana Castanheira
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021). Open forum infectious diseases 10 (2) (2023)
Michael A Pfaller, Dee Shortridge, Cecilia Godoy Carvalhaes, Mariana Castanheira
Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021. Microbiology spectrum (2023)
Michael D Huband, Kelley A Fedler, Helio Silva Sader, Gregory G Stone, Mariana Castanheira
Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination. Journal of clinical microbiology (2023)
Lalitagauri M Deshpande, Silvio Vega, Juan Carlos Tinoco, Mariana Castanheira
Endemicity of Pseudomonas aeruginosa producing IMP-18 and/or VIM-2 MBLs from the high-risk clone ST111 in Central America. JAC-antimicrobial resistance 5 (4) (2023)
Joshua M Maher, Michael D Huband, Christopher G Blankers, Sailaja Puttagunta, Steven I Aronin, Mariana Castanheira
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Aurveillance Program. The Journal of antimicrobial chemotherapy (2023)
Rodrigo Elisandro Mendes, S J Ryan Arends, Jennifer M Streit, Ian Critchley, Nicole Cotroneo, Mariana Castanheira
Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020). Microbiology spectrum 11 (1) (2023)
Dee Shortridge, Valerie Kantro, Mariana Castanheira
Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates. Microbiology spectrum (2023)
Helio Silva Sader, Mariana Castanheira, John H Kimbrough, Valerie Kantro, Rodrigo Elisandro Mendes
Aztreonam/avibactam activity against a large collection of carbapenem-resistant Enterobacterales (CRE) collected in hospitals from Europe, Asia and Latin America (2019-21). JAC-antimicrobial resistance 5 (2) (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, John H Kimbrough, Valerie Kantro, Mariana Castanheira
Impact of the Recent Clinical and Laboratory Standards Institute Breakpoint Changes on the Antimicrobial Spectrum of Aminoglycosides and the Activity of Plazomicin Against Multidrug-Resistant and Carbapenem-Resistant Enterobacterales From United States Medical Centers. Open forum infectious diseases 10 (2) (2023)
Mariana Castanheira, John H Kimbrough, Sean DeVries, Rodrigo Elisandro Mendes, Helio Silva Sader
Trends of β-Lactamase Occurrence Among Escherichia coli and Klebsiella pneumoniae in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type. Open forum infectious diseases 10 (2) (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum (2023)
Michael A Pfaller, Rodrigo Elisandro Mendes, Helio Silva Sader, Mariana Castanheira, Cecilia Godoy Carvalhaes
Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010-2019). Journal of chemotherapy (Florence, Italy) (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum 11 (1) (2023)
Helio Silva Sader, Rodrigo Elisandro Mendes, Cecilia Godoy Carvalhaes, John H Kimbrough, Mariana Castanheira
Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019-2021). Open forum infectious diseases 10 (2) (2023)
Rodrigo Elisandro Mendes, S J Ryan Arends, Jennifer M Streit, Ian Critchley, Nicole Cotroneo, Mariana Castanheira
Contemporary Evaluation of Tebipenem In Vitro Activity against Enterobacterales Clinical Isolates Causing Urinary Tract Infections in US Medical Centers (2019-2020). Microbiology spectrum 11 (1) (2023)
Mariana Castanheira, Timothy B Doyle, Cory M Hubler, Sean DeVries, Dee Shortridge
Vaborbactam increases meropenem susceptibility in Pseudomonas aeruginosa clinical isolates displaying MexXY and AmpC upregulation. mSphere (2023)
Dee Shortridge, Valerie Kantro, Mariana Castanheira
Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant Enterobacterales Strains, Including Carbapenem-Resistant Isolates. Microbiology spectrum 11 (1) (2023)
S J Ryan Arends, Deborah Butler, Nicole E Scangarella-Oman, Mariana Castanheira, Rodrigo Elisandro Mendes
Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020). Antimicrobial agents and chemotherapy (2023)
Cecilia Godoy Carvalhaes, Dee Shortridge, Leah N Woosley, Nabina Gurung, Mariana Castanheira
Performance of the Vitek 2 Advanced Expert System (AES) as a Rapid Tool for Reporting Antimicrobial Susceptibility Testing (AST) in Enterobacterales from North and Latin America. Microbiology spectrum 11 (1) (2023)
Mariana Castanheira, John H Kimbrough, Sean DeVries, Rodrigo Elisandro Mendes, Helio Silva Sader
Trends of β-Lactamase Occurrence Among Escherichia coli and Klebsiella pneumoniae in United States Hospitals During a 5-Year Period and Activity of Antimicrobial Agents Against Isolates Stratified by β-Lactamase Type. Open forum infectious diseases 10 (2) (2023)
M A Pfaller, Michael D Huband, P R Rhomberg, P A Bien, Mariana Castanheira
Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020). Antimicrobial agents and chemotherapy 66 (11) (2022)
David L Paterson, Matteo Bassetti, Mary Motyl, Matthew G Johnson, Mariana Castanheira, Erin H Jensen, Jennifer A Huntington, Brian Yu, Dominik J Wolf, Christopher J Bruno
Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Dee Shortridge, Jennifer M Streit, Rodrigo Elisandro Mendes, Mariana Castanheira
In Vitro Activity of Cefiderocol against U.S. and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program. Microbiology spectrum 10 (2) (2022)
Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo Elisandro Mendes, Timothy B Doyle, Helio Silva Sader
Prevalence of carbapenemase genes among carbapenem-nonsusceptible Enterobacterales collected in US hospitals in a five-year period and activity of ceftazidime/avibactam and comparator agents. JAC-antimicrobial resistance 4 (5) (2022)
Cecilia Godoy Carvalhaes, Paul R Rhomberg, Michael A Pfaller, Jeffrey B Locke, Mariana Castanheira
Evaluation of the Post-Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata. Mycoses 65 (11) (2022)
Helio Silva Sader, Rodrigo Elisandro Mendes, S J Ryan Arends, Cecilia Godoy Carvalhaes, Mariana Castanheira
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (3) (2022)
Helio Silva Sader, Rodrigo E Mendes, Leonard R Duncan, Cecilia Godoy Carvalhaes, Mariana Castanheira
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018-19). The Journal of antimicrobial chemotherapy 77 (10) (2022)
Maiken Cavling Arendrup, Sevtap Arikan-Akdagli, Mariana Castanheira, Jesus Vicente Guinea, Jeffrey B Locke, Joseph Meletiadis, Óscar Zaragoza
Multicentre validation of a modified EUCAST MIC testing method and development of associated epidemiologic cut-off (ECOFF) values for rezafungin. The Journal of antimicrobial chemotherapy (2022)
Helio Silva Sader, Mariana Castanheira, Michael D Huband, Dee Shortridge, Cecilia Godoy Carvalhaes, Rodrigo Elisandro Mendes
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (5) (2022)
Michael A Pfaller, Cecilia Godoy Carvalhaes, Sean DeVries, Paul Richard Rhomberg, Mariana Castanheira
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections. Medical mycology 60 (5) (2022)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Paul Richard Rhomberg, Mariana Castanheira, Sean DeVries, Rodrigo Elisandro Mendes
Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019). The Pediatric infectious disease journal 41 (9) (2022)
Rodrigo Elisandro Mendes, Cory M Hubler, John H Kimbrough, Valerie Kantro, Ian A Critchley, Nicole Cotroneo, Mariana Castanheira
In Vitro Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020). Antimicrobial agents and chemotherapy 66 (10) (2022)
Thomas R Rogers, Paul E Verweij, Mariana Castanheira, Eric Dannaoui, P Lewis White, Maiken Cavling Arendrup, null null
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications. The Journal of antimicrobial chemotherapy 77 (8) (2022)
Dee Shortridge, Lalitagauri M Deshpande, Jennifer M Streit, Mariana Castanheira
Activity of meropenem/vaborbactam and comparators against non-carbapenemase-producing carbapenem-resistant Enterobacterales isolates from Europe. JAC-antimicrobial resistance 4 (5) (2022)
Cecilia Godoy Carvalhaes, Abby L Klauer, Paul Richard Rhomberg, Michael A Pfaller, Mariana Castanheira
Evaluation of Rezafungin Provisional CLSI Clinical Breakpoints and Epidemiological Cutoff Values Tested against a Worldwide Collection of Contemporaneous Invasive Fungal Isolates (2019 to 2020). Journal of clinical microbiology 60 (4) (2022)
Olga Lomovskaya, Debora Rubio-Aparicio, Kirk Nelson, Dongxu Sun, Ruslan Tsivkovski, Mariana Castanheira, Jill Lindley, Jeffery Loutit, Michael Dudley
In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy 65 (6) (2021)
Cecilia Godoy Carvalhaes, Helio Silva Sader, Jennifer M Streit, Mariana Castanheira, Rodrigo Elisandro Mendes
Activity of Oritavancin Against Gram-positive Pathogens Causing Bloodstream Infections in the United States Over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010-2019). Antimicrobial agents and chemotherapy (2021)
Michael A Pfaller, Shawn A Messer, Lalitagauri M Deshpande, Paul R Rhomberg, Eric A Utt, Mariana Castanheira
Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program. Antimicrobial agents and chemotherapy 65 (4) (2021)
Casey L Cazer, Lars F Westblade, Matthew S Simon, Reed Magleby, Mariana Castanheira, James G Booth, Stephen G Jenkins, Yrjö T Gröhn
Analysis of Multidrug Resistance in Staphylococcus aureus with a Machine Learning-Generated Antibiogram. Antimicrobial agents and chemotherapy 65 (4) (2021)
Dee Shortridge, S J Ryan Arends, Jennifer M Streit, Mariana Castanheira
Minocycline Activity against Unusual Clinically Significant Gram-Negative Pathogens. Antimicrobial agents and chemotherapy 65 (11) (2021)
Michael D Huband, Jennifer D Thompson, Nabina D Gurung, Qingmei Liu, Li Li, Jay Zhang, Jennifer M Streit, Mariana Castanheira
Activity of KBP-7072 (a novel aminomethylcycline) and comparators against 1,057 geographically diverse recent clinical isolates from the SENTRY Surveillace Program (2019). Antimicrobial agents and chemotherapy (2021)
Mariana Castanheira, Matthew G Johnson, Brian Yu, Jennifer A Huntington, Patricia Carmelitano, Christopher Bruno, Elizabeth G Rhee, Mary Motyl
Molecular Characterization of Baseline Enterobacterales and Pseudomonas aeruginosa Isolates from a Phase 3 Nosocomial Pneumonia (ASPECT-NP) Clinical Trial. Antimicrobial agents and chemotherapy 65 (3) (2021)
Mariana Castanheira, Timothy D Collingsworth, Andrew P Davis, Lalitagauri M Deshpande, Michael A Pfaller
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously associated with resistance to other azoles. Mycoses 64 (10) (2021)
Rodrigo Elisandro Mendes, Paul Richard Rhomberg, Troy Lister, Nicole Cotroneo, Thomas R Parr, Mariana Castanheira
In Vitro Activity Analysis of a New Polymyxin, SPR741, Tested in Combination with Antimicrobial Agents against a Challenge Set of Enterobacteriaceae, Including Molecularly Characterized Strains. Antimicrobial agents and chemotherapy 65 (1) (2020)